Paget's disease of bone

Journal of Bone and Mineral Research

Volumn 13, Issue 7, 1998, Pages 1061-1065

  Siris, Ethel S ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID;

BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; DISEASE COURSE; HUMAN; OSTEOCLAST; OSTEOLYSIS; PAGET BONE DISEASE; PARAMYXOVIRUS; REVIEW; SYMPTOMATOLOGY;

BONE DENSITY; CHROMOSOMES, HUMAN, PAIR 18; DIPHOSPHONATES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OSTEITIS DEFORMANS; RESPIROVIRUS INFECTIONS;

EID: 0031861810     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.7.1061     Document Type: Review

References (53)

1. Gold DT, Boisture J, Shipp KM, Pieper CF, Lyles KW 1996 Paget's disease of bone and quality of life. J Bone Miner Res 11:1897-1904.
2. Mills BG, Singer FR 1987 Critical evaluation of viral antigen data in Paget's disease of bone. Clin Orthop 217:16-25.
3. Barry HC 1969 Paget's Disease of Bone. Churchill-Livingstone, Edinburgh, U.K.
4. Rebel A, Malkani K, Basle J 1974 Anomalies nucleaires des osteoclasts de la maladic osseuse de Paget. Nouv Presse Med 3:1299-1301.
5. Mills BG, Singer FR 1976 Nuclear inclusions in Paget's disease of bone. Science 194:201-202.
6. Basle MF, Fournier JG, Rozenblatt S, Rebel A, Boutielle M 1986 Measles virus mRNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907-913.
7. Gordon MT, Anderson DC, Sharpe PT 1991 Canine distemper virus localized in bone cells of patients with Paget's disease. Bone 12:195-201.
8. Gordon MT, Mee AP, Anderson DC, Sharpe PT 1992 Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner 19:159-174.
9. Ralston SH, Digiovine FS, Gallacher SJ, Boyle IT, Duff GW 1991 Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J Bone Miner Res 6:1243-1248.
10. Birch MA, Taylor W, Fraser WD, Ralston SH, Hart CA, Gallagher JA 1994 Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res 9:11-16.
11. Reddy SV, Singer FR, Roodman GD 1995 Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 80:2108-2111.
12. Reddy SV, Singer FR, Mallette L, Roodman GD 1996 Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget's disease. J Bone Miner Res 11:1602-1607.
13. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, Singer FR 1992 Interleukin-6: A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52.
14. Hoyland JA, Freemont AJ, Sharpe PT 1994 Inteleukin-6, IL-6 receptor and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:75-80.
15. Mills BG, Yabe H, Singer FR 1988 Osteoclasts in human ostcopctrosis contain viral nucleocapsid-like nuclear inclusions. J Bone Miner Res 3:101-106.
16. McKusick VA 1972 Heritable Disorders of Connective Tissue. CV Mosby, St. Louis, MO, U.S.A., pp. 718-737.
17. Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G 1995 Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 10:663-670.
18. Siris ES, Ottman R, Flaster E, Kelsey JL 1991 Familial aggregation of Paget's disease of bone. J Bone Miner Res 6:495-500.
19. Tilyard MW, Gardner RJM, Milligan L, Cleary TA, Stewart RD 1982 A probable linkage between familial Paget's disease and the HLA loci. Aust NZ J Med 12:498-500.
20. Foldes J, Shamir S, Brautbar C, Schermann L, Menczel J 1991 HLA-D antigens and Paget's disease of bone. Clin Orthop 266:301-303.
21. Singer FR, Mills BG, Park MS, Takemura S, Terasaki PI 1985 Increased HLA-DQW1 antigen pattern in Paget's disease. Clin Res 33:574A.
22. Singer FR, Siris ES, Knieriem A, Gjertson D, Terasaki PI 1996 The HLA DRB1*1104 gene frequency is increased in Ashkenazi Jews with Paget's disease of bone. J Bone Miner Res 11:S369.
23. Cody JD, Singer FR, Roodman GD, Otterund B, Lewis TB, Leppert M 1997 Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet 61:1117-1122.
24. Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL, Nakatsuka K, Willems P, Haites NE, Ralston SH 1998 Paget's disease of bone: Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res 13:911-917.
25. Hughes AE, Shearmen AM, Weber JL, Barr RJ, Wallace RG, Osterberg PH, Nevin NC, Mollan RAB 1994 Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet 3:359-361.
26. DeRose J, Singer F, Avramides A, Flores A, Dziadiw R, Baker R, Wallach S 1974 Response of Paget's disease to porcine and salmon calcitonins. Am J Med 56:858-866.
27. Siris ES, Canfield RE, Jacobs TP, Stoddart KE, Spector PJ 1981 Clinical and biochemical effects of EHDP in Paget's disease: Patterns of response to initial treatment and to long term therapy. Metab Bone Dis Rel Res 5:301-308.
28. Meunier PJ, Vignot E 1995 Therapeutic strategy in Paget's disease of bone. Bone 17:489S-491S.
29. Cantrill JA, Buckler HM, Anderson DC 1986 Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of the bone. Ann Rheum Dis 45:1012-1018.
30. Gallacher SJ, Boyce BF, Patel U, Jenkins A, Ralston SH, Boyle IT 1991 Clinical experience with pamidronate in the treatment of Paget's disease of bone. Ann Rheum Dis 50:930-933.
31. Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL 1987 Paget's disease of bone: Early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J 295:1301-1305.
32. Patel S, Stone MD, Coupland C, Hosking DJ 1993 Determinants of remission in Paget's disease of bone. J Bone Miner Res 8:1467-1473.
33. Thiebaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P 1988 A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am J Med 85:207-212.
34. Wimalawansa SJ, Gunasekera RD 1993 Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcif Tissue Int 53:237-241.
35. Bombassei GJ, Yocono M, Raisz LG 1994 Effects of intravenous pamidronate therapy on Paget's disease of bone. Am J Med Sci 308:226-233.
36. Vega E, Gonzalez D, Ghiringhelli G, Mautalen C 1987 Intravenous aminopropylidene bisphosphonate in the treatment of Paget's bone disease. J Bone Miner Res 2:267-271.
37. Siris ES 1994 Perspectives: A practical guide to the use of pamidronate in Paget's disease. J Bone Miner Res 9:303-304.
38. Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF 1993 Mineralisation defects after pamidronate in Paget's disease. Lancet 342:1459-1460.
39. Meunier PJ, Alexandre C, Edouard C, Mathieu L, Chapuy MC, Bressot C, Vignon E, Trechsel U 1979 Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Lancet 2:489-492.
40. Delmas PD, Chapuy MC, Vignon E, Charon S, Briancon D, Alexandre C, Edouard C, Meunier PJ 1982 Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. J Clin Endocrinol Metab 54:837-844.
41. Yates AJP, Gray RES, Urwin GH, Preston CJ, Russell RGG, Percival RC, Atkins RM, Hamdy NAT, Beneton MNC, Kanis JA 1985 Intravenous clodronate in the treatment and retreatment of Paget's disease of bone. Lancet 1:1474-1477.
42. Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M 1995 Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Arthritis Rheum 38:851-858.
43. McClung MR, Tou CPK, Goldstein NH, Picot C 1995 Tiludronate therapy for Paget's disease of bone. Bone 17:493S-496S.
44. Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, Lyles K, Mcllwain H, Murphy WA, Reda R, Rude R, Seton M, Tiegs R, Thompson D, Tucci JR, Yates AJ, Zimring M 1996 Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961-967.
45. Reid IR, Nicholson GC, Weinstein RS, Hosking D, Cundy T, Kotowicz MA, Murphy WA, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ 1996 Biochemical and radiologie improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial. Am J Med 171:341-348.
46. Miller PD, Adachi JD, Brown JP, Khairi RA, Lang R, Licata AA, McClung MR, Ryan WR, Singer FR, Siris ES, Tenen-house A, Wallach S, Bekker PJ, Axelrod DW 1997 Risedronate vs. etidronate: Durable remission with only two months of 30 mg risedronate. J Bone Miner Res 12:S270.
47. Siris ES, Chines AA, Altman RD, Brown JP, Johnston CC, Lang R, McClung MR, Mallette LE, Miller PD, Ryan WG, Singer FR, Tucci JR, Eusebio RA, Bekker PJ 1998 Risedronate in the treatment of Paget's disease: An open-label, multicenter study. J Bone Miner Res 13:1032-1038.
48. Atkins RM, Yates AJP, Gray RES, Urwin GH, Hamdy NAT, Beneton MNC, Rosini S, Kanis JA 1987 Aminohexane diphosphonate in the treatment of Paget's disease of bone. J Bone Miner Res 2:273-279.
49. Delmas PD, Chapuy MC, Edouard C, Meunier PJ 1987 Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. Am J Med 83:276-282.
50. Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OLM, Papapoulos SE 1993 Improved treatment of Paget's disease with dirnethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 8:175-182.
51. Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer AV, Zelenakas K 1997 Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone, Calcif Tissue Int 60:415-418.
52. Bockman RS, Wilhelm F, Siris E, Singer F, Chausmer A, Bitton R, Kotler J, Levenson D 1995 A multicenter trial of gallium nitrate in patients with advanced Paget's disease of bone. J Clin Endocrinol Metab 80:595-602.
53. Cundy T, Wattie D, King AR 1996 High dose pamidronate in the management of resistant Paget's disease. Calcif Tissue Int 58:6-8.